Quarterly Report • Nov 21, 2022
Quarterly Report
Open in ViewerOpens in native device viewer
Company AS PRFoods
Type Company Release
Category Management interim statement or quaterly financial report
Disclosure time 21 Nov 2022 23:27:52 +0200
Attachments:
PRF_interim_3m2022_2023 aruanded FINAL.pdf (http://oam.fi.ee/en/download?id=6918)
PRF_vahearuanne_3k2022_2023 FINAL.pdf (http://oam.fi.ee/en/download?id=6919)
Title
Consolidated Unaudited Interim Report of AS PRFoods for the 1nd quarter and 3 months of
Consolidated Unaudited Interim Report of AS PRFoods for the 1nd quarter and 3 months of 2022/2023 financial year
In 2022 we have sold both Finnish and Swedish business units. First was sold because of continued losses and Sweden was sold to reduce overall debt level. As compared to last year, the biggest difference is that we no longer have sales from Finnish production units, in fish farming we no longer hold Finnish and Swedish assets and also fish harvesting was postponed until Q2.
In fish farming as said, harvesting was postponed until Q2. Fish products saw significant decline to overall market in demand for smoked fish products due to historically highest raw material prices and this is reflected in results. In Q2 we see decline in fish prices, and recovery of demand, but overall consumption per country is lower by 30-50%. UK unit performs according to expectations, but decline in private label demand in Finland, has negative impact on results of Saare Kala Tootmine OÜ. Swedish fish farming was sold at the end of Q1 and as per agreement, final payment for the shares will take place in 2023. Extraordinary profit in Q1 was result of sale of Swedish unit.
KEY RATIOS
INCOME STATEMENT
| +-------------------------+---------+---------+---------+---------+---------+ | ||||
|---|---|---|---|---|
1Q |
1Q |
1Q | ||
| mln EUR | 2022/2023 2021/2022 2021/2022 2020/2021 2020/2021 | |||
| +-------------------------+---------+---------+---------+---------+---------+ |

| Sales | 4,6 | 42,1 | 14,2 2 | 58,71 | 18,5 |
|---|---|---|---|---|---|
| Gross profit | 0 , 5 | 3 , 1 | 0 , 8 | ഗ | ଧ |
| EBITDA from operations | -0 , 3 | -1 , 7 | -0,8 | -1 , 2 | o |
| EBITDA | -0,5 | -2 , 1 | 0,0 | -1 , 3 | -0,91 |
| EBIT | -0 ,8 | -4 , 2 | -0 , 7 | -3,9 | -1 , 4 |
| EBT | 0,9 | -8 , 2 | -0,6 | -5 | -1 ,8 |
| Net profit (-loss) | 0,91 | -8 , 2 | -0 , 7 | -5 , 2 | ---+ -1 , 7 |
| Gross marqin | 11 , 1% | 7 , 44% | 5 , 4% | 8 , 50% | 10 , 80% |
| Operational EBITDA margin | -6 , 9% | -4 , 06% | -5 , 5% | -2,10% | 0,10% |
| EBITDA margin | -10,6% - |
-5 , 05% | -0 , 1% | -2,10% | -4 , 6% |
| EBIT margin | -17 , 7% | -9 , 93% | -4 , 7 % | -6,60% | -7,8% |
| EBT marqin | -19 , 0% | -19 , 52% | -4,6% | -8,50% | -9,80% |
| Net marqin | 18 , 8% | -19,37% | -5 , 2% | -8 , 80% | -9 , 20% |
| Operating expense ratio | -24 , 2% | -17 , 11% | 16 , 3% | 16 , 10% | 14 , 30% |
| mln EUR | 30.09.2022 30.06.2022 30.09.2021 30.06.2021 30.09.2020 | ||||
|---|---|---|---|---|---|
| Net debt | 18,8 | ||||
| Equity | 8,0 | 8,1 | 14 , 9 | 15,8 | |
| Working capital | 0,7 | -3 , 2 | -2 - 2 - 9 | -4 , 4 , 4 , |
| ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Assets + - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - |
|||
|---|---|---|---|
| Liquidity ratio + - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - |
|||
| Equity ratio + - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - |

| 70,2% 75,4% 61,8% 56,9% 53,7% Debt to total assets Net debt to EBITDA op -59,3x -14,5x -14,3x -16,9x 12,8x 7,6% -68,5% -26,7% -26,7% =28,7% -7,0% 2,0% =17,3% |
||
|---|---|---|
Consolidated Statement of Financial Position
| Thousand euros | 30.09.2022 30.09.2021 30.06.2022 | ||
|---|---|---|---|
| ASSETS | |||
| Cash and cash equivalents | 3 45 | 748 | 110 |
| Receivables and prepayments | 4 811 | 3 231 | 2 567 |
| Inventories | 2 102 | 5 638 | 2 196 |
| Biological assets | ರಿ 5 5 | 7 746 | 3 003 |
| Total current assets | 8 213 | 17 363 | 7 876 |
| Deferred income tax | 38 | ਰੇ 3 | |
| Long-term financial investments | 304 | 305 | 229 |
| Tangible fixed assets | 7 169 | 14 897 | 8 882 |
| Intangible assets | 17 400 | 23 368 | 21 837 |
| Total non-current assets | 24 873 | 38 608 - |
31 041 |
| TOTAL ASSETS | 33 086 | 55 971 | 38 917 |
| EQUITY AND LIABILITIES | |||
| Loans and borrowings | 3 562 | 6 521 | 7 094 |
| Payables | 3 965 | 13 219 | 3 978 |

| Government grants | 207 | o | |
|---|---|---|---|
| Total current liabilities | 7 527 | 19 947 | 11 072 |
| Loans and borrowings | 15 592 | 18 411 | 17 725 |
| Payables | O | 204 | |
| Deferred tax liabilities | 1 644 | 1 996 | 1 599 |
| Government grants | 342 | ୧ ବଟ | 265 |
| Total non-current liabilities | 17 578 | 21 102 | 19 792 |
| TOTAL LIABILITIES | 25 105 | 41 049 | 30 865 |
| Share capital | 7 737 | 7 737 | 7 737 |
| Share premium | 14 007 | 14 007 | 14 007 |
| Treasury shares | - 390 | -390 | -390 |
| Statutory capital reserve | 51 | 51 | 51 |
| Currency translation reserve | 3 9 4 | 447 | 839 |
| Retained profit (-loss) | 14 043 | -7 641 | -14 391 |
Equity attributable to parent 7 756 14 211 7 853
| . Non-controlling interest |
--------------------------------- | |
|---|---|---|
| TOTAL EQUITY ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
7 980 14 922 8 052 | |
| TOTAL EQUITY AND LIABILITIES 33 086 55 971 38 917 |
Consolidated Statement of Profit or Loss And Other Comprehensive Income
| nousand eilros | 3k 2022/2023 3k 2021/2022 | ||
|---|---|---|---|

| Sales | 4 610 | 14 207 |
|---|---|---|
| Cost of goods sold | -4 097 | -13 433 |
| Gross profit | 514 | 774 |
| Operating expenses | -1 114 | -2 309 |
| Selling and distribution expenses | -643 | -1 581 |
| Administrative expenses | -471 | -728 |
| Other income / expense | -47 | 51 |
| Fair value adjustment on biological assets | -170 | 820 |
| Operating profit ( loss ) | -817 | -664 |
| Financial income/-expenses | 1 692 | 16 |
| Profit (loss) before tax | 874 | -648 |
| Income tax | -6 | -92 |
| Net profit (loss) for the period | 868 | -740 |
| Net profit (loss) attributable to: | ||
| Owners of the company | 878 | -918 |
| Non-controlling interests | -8 | 178 |
| Total net profit (loss) | 869 | -740 |
| Other omprehensive income (loss) that may subsequently be classified to profit or loss: |
||
| Foreign currency translation differences | -445 | -112 |
| Total comprehensive income (expense) | 424 | -852 |

| Total comprehensive income (expense) attributable to: +----------------------------------------------------+------------+------------+ |
||
|---|---|---|
| Owners of the Company | 433 |
-842 |
| +----------------------------------------------------+------------+------------+ Non-controlling interests |
- 8 |
-10 |
| +----------------------------------------------------+------------+------------+ Total comprehensive income (expense) for the period |
424 | -852 |
| +----------------------------------------------------+------------+------------+ |
||
| +----------------------------------------------------+------------+------------+ Profit (loss) per share (EUR) |
0,02 |
-0,02 |
| +----------------------------------------------------+------------+------------+ |
||
| +----------------------------------------------------+------------+------------+ Diluted profit (loss) per share (EUR) |
0,02 |
-0,02 |
| +----------------------------------------------------+------------+------------+ |
Indrek Kasela
AS PRFoods Member of the Management Board Phone:+372 452 1470
www.prfoods.ee

Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.